Wed, Dec 26 2007 5:14 PM MultiCell Technologies To Increase Focus on Therapeutic Candidates Wed, Oct 10 2007 10:23 AM MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated Thu, July 19 2007 8:00 AM MultiCell Technologies and Fusion Capital Terminate Common Stock Purchase Agreement Thu, May 03 2007 9:00 AM MultiCell Technologies Receives Two International Trademark Protections Tue, Apr 24 2007 8:00 AM MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 Cell Line for Drug Discovery/ADMETOX Applications Wed, Apr 18 2007 9:00 AM MultiCell Technologies Signs Key Formulation and Supply Agreement With Merck KGaA & Co. Spittal/Drau Mon, Apr 9 2007 9:30 AM MultiCell Technologies Signs Key Supply Agreement With Lundbeck Pharmaceuticals Italy S.p.A. Wed, Mar 21 2007 10:38 AM MultiCell Technologies Announces a New Class of Patented Therapeutics Tue, Mar 6 2007 7:28 PM MultiCell Technologies Completes Private Financing Agreement with La Jolla Cove Investors for up to $13 Million to Support Development of Advanced Therapeutics Thu, Feb 15 2007 3:30 AM MultiCell Technologies Announces Prospective Cancer Treatment Drug Tue, Feb 6 2007 3:30 AM MultiCell Technologies Announces Progress for MCT-125's Anticipated Phase IIb Clinical Trial Thu, Jan 11 2007 6:30 AM MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer Fri, Dec 15 2006 6:30 AM MultiCell Technologies Fulfills Upfront License Fee Payment Obligation to Amarin Neuroscience for MCT-125 Wed, Dec 6 2006 5:04 PM MultiCell Technologies Discusses Recent Cancer Treatment Breakthrough and Growing Intellectual Property Portfolio with CEOcast.com Investor Information Service Wed, Nov 29 2006 6:30 AM MultiCell Technologies Obtains Patent Protection in Several European Countries for Treatment of Autoimmune Diseases Mon, Nov 27 2006 4:01 PM MultiCell Technologies Releases CEO Letter to Shareholders Wed, Nov 22 2006 6:30 AM WebAlert: MultiCell Technologies Presenting during SmallCapInsights.com's ''Emerging Growth Forum'' Starting Today at 12 Noon ET Tue, Nov 21 2006 9:25 AM Multicell Technologies Demonstrates Drug Candidate's Powerful Tumor-Destroying Capabilities for Virally Induced Cancers such as Cervical Cancer Mon, Nov 20 2006 10:06 AM MultiCell Technologies and SmallCapInsights.com Highlight CEOs Presenting at Wednesday's Anticipated ``Emerging Growth Forum'' Mon, Nov 20 2006 9:25 AM MultiCell Technologies to Seek Advanced Human Clinical Trials for Lead Therapeutics Program Thu, Nov 16 2006 4:03 PM MultiCell Technologies Announces SmallCapInsights.com to Host ''Emerging Growth Forum'' Webcast Highlighting Auriga Laboratories, MultiCell Technologies, Peace Arch Entertainment and Titan Global Holdings Tue, Nov 7 2006 4:01 PM MultiCell Technologies CEO to Present Key Research Data at New York Academy of Sciences' Animal Models Conference Wed, Nov 01 2006 4:32 PM MultiCell Technologies Posts Journal Article on Research Leading to Company's Recent Patent Application on Novel Cancer Treatment Tue, Oct 31 2006 11:23 AM MultiCell Technologies Releases Transcript of Recent Investor Conference Call Discussing Recent Growth Initiatives and Growth of IP Portfolio Thu, Oct 26 2006 11:43 AM MultiCell Technologies Recaps New Investor Conference Call Discussing Recent Drug Development Initiatives and Strengthened IP Portfolio Wed, Oct 25 2006 06:30 AM WebAlert: MultiCell Technologies Investor Conference Call Starts Today at 12 Noon ET Thu, Oct 12 2006 4:03 PM MultiCell Technologies Announces Milestone Patent Issued by European Patent Office on Treatments for Autoimmune Diseases Wed, Oct 11 2006 4:02 PM WebAlert: MultiCell Technologies to Release CEO Interview to Discuss Progress in Business and Drug Development Programs Wed, Oct 11 2006 6:00 PM MultiCell Outlines Portfolio of Next-Generation Immune Modulation Therapeutics Technology in Updated Investor Fact Sheet Fri, Oct 6 2006 4:01 PM MultiCell Announces ?ntellectual Property Portfolio of First-in-Class Technologies Crosses Threshold of 50 Issued or Pending Patents Thu, Oct 5 2006 6:22 PM MultiCell and Fusion Capital Amend and Restate Common Stock Purchase Agreement to Provide for $8 Million of Equity Funding Thu, Oct 5 2006 6:00 PM MultiCell Technologies Announces Strategic Initiatives for 2006 and 2007; Company to Focus on Advance of First-in-Class Immune-based Drug Candidates into Advanced Phase Human Clinical Trials Tue, Oct 3 2006 3:03 PM SmallCapInsights.com Investment Newsletter Commences Editorial Coverage of MultiCell Technologies Following Recently Filed Patent on Cancer Treatment